PACB
PACB
NASDAQ · Life Sciences Tools & Services

Pacific Biosciences Of Calif

$1.37
-0.01 (-0.72%)
As of Sep 20, 10:25 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 9 64%
Hold 4 29%
Sell 1 7%
Price Target
Analyst Price Target +3,323.4% upside
Low Target $34.06
Average Target $46.90
High Target $60.93
Current Price $1.37
Current
$1.37
Target
$46.90
$34.06 $46.90 avg $60.93
Scenario Analysis
Bear Case
$34.06
2,386.1%
Low target
Base Case
$46.90
+3,323.4%
Avg target
Bull Case
$60.93
+4,347.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.73
-49.8% from high
52-Week Low
$1.07
+28.0% from low
Target vs 52W High
$46.90
+1,617.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -44.0%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -26.7%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.3%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -60.1%
WAT
Waters Corp
Buy 31 65% $189.60 -55.3%
ILMN
Illumina Inc
Buy 28 57% $169.36 -29.1%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -62.3%